Vivosim Labs, Inc.盘中异动急速上涨5.41%_老虎社区_美港股上老虎

Vivosim Labs, Inc.盘中异动急速上涨5.41%

市场透视02-26

北京时间2026年02月26日04时11分，Vivosim Labs, Inc.（VIVS.us）股票出现异动，股价快速上涨5.41%。截至发稿，该股报2.05美元/股，成交量9.103万股，换手率3.49%，振幅6.70%。最近的财报数据显示，该股实现营业收入26000.00美元，净利润-2.69百万美元，每股收益-1.03美元，毛利-26000.00美元，市盈率1.15倍。机构评级方面，目前...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2614049751?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-26 04:11","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2614049751","market":"us","top_or_hot":-1,"title":"Vivosim Labs, Inc.盘中异动 急速上涨5.41%","media":"市场透视","content":"<div>\n<p>北京时间2026年02月26日04时11分，Vivosim Labs, Inc.（VIVS.us）股票出现异动，股价快速上涨5.41%。截至发稿，该股报2.05美元/股，成交量9.103万股，换手率3.49%，振幅6.70%。最近的财报数据显示，该股实现营业收入26000.00美元，净利润-2.69百万美元，每股收益-1.03美元，毛利-26000.00美元，市盈率1.15倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivosim Labs, Inc.盘中异动 急速上涨5.41%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivosim Labs, Inc.盘中异动 急速上涨5.41%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-26 04:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2026年02月26日04时11分，Vivosim Labs, Inc.（VIVS.us）股票出现异动，股价快速上涨5.41%。截至发稿，该股报2.05美元/股，成交量9.103万股，换手率3.49%，振幅6.70%。最近的财报数据显示，该股实现营业收入26000.00美元，净利润-2.69百万美元，每股收益-1.03美元，毛利-26000.00美元，市盈率1.15倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBD","symbol_name":"Inspire Corporate Bond ETF","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b","article_id":"2614049751","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614049751","pubTimestamp":1772050297,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2026年02月26日04时11分，Vivosim Labs, Inc.股票出现异动，股价快速上涨5.41%。Vivosim Labs, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Vivosim Labs, Inc.公司简介：VivoSim Labs Inc前身为Organovo Holdings Inc，是一家生物技术公司，专注于开发FXR314治疗炎症性肠病，包括溃疡性结肠炎，基于三维人体组织的临床前景证明以及临床前数据。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IBD":"Inspire Corporate Bond ETF","VIVS":"VivoSim Lab, Inc.","BK4139":"生物科技"},"translate_title":"Vivosim Labs, Inc. surged 5.41% in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIVS":0.9,"IBD":1},"content_text":"北京时间2026年02月26日04时11分，Vivosim Labs, Inc.（VIVS.us）股票出现异动，股价快速上涨5.41%。截至发稿，该股报2.05美元/股，成交量9.103万股，换手率3.49%，振幅6.70%。最近的财报数据显示，该股实现营业收入26000.00美元，净利润-2.69百万美元，每股收益-1.03美元，毛利-26000.00美元，市盈率1.15倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Vivosim Labs, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Larimar Therapeutics, Inc.、Moolec Science Sa C/Wts 30/01/2028(To Pur Com)、Cardio Diagnostics Holdings Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Quince Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为677.47%、245.67%、149.94%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028(To Pur Com)、Larimar Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026(To Pur Com)，振幅分别为141.12%、75.07%、69.57%。Vivosim Labs, Inc.公司简介：VivoSim Labs Inc前身为Organovo Holdings Inc，是一家生物技术公司，专注于开发FXR314治疗炎症性肠病(IBD)，包括溃疡性结肠炎(UC)，基于三维(3D)人体组织的临床前景证明以及临床前数据。FXR是胃肠道和肝脏疾病的媒介。该公司目前提供肝脏毒理学预测筛选和研究服务，并致力于预测和研究制药和生物技术公司在药物开发各个阶段的候选药物的肠道副作用特征。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}